UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000035301 |
|---|---|
| Receipt number | R000040220 |
| Scientific Title | Monoamine metabolite levels in schizophrenia correlate with mismatch negativity |
| Date of disclosure of the study information | 2018/12/19 |
| Last modified on | 2018/12/18 16:50:09 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Monoamine metabolite levels in schizophrenia correlate with mismatch negativity
Acronym
Monoamine metabolite in schizophrenia correlates with MMN
Scientific Title
Monoamine metabolite levels in schizophrenia correlate with mismatch negativity
Scientific Title:Acronym
Monoamine metabolite in schizophrenia correlates with MMN
Region
| Japan |
Condition
Condition
Schizphrenia
Classification by specialty
| Psychiatry |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
The principal aim of this study is to reveal the relation between mismatch negativity and monoamine levels in patients with schizophrenia.
Basic objectives2
Others
Basic objectives -Others
None
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Correlation between amplitude of mismatch negativity and level of homovanillic acid (HVA) and 5-hydroxyindole acetic acid (5-HIAA) collected from patients' serum.
Key secondary outcomes
Base
Study type
Observational
Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Japanese patients diagnosed with schizophrenia according to the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. All participants are right-handed and undergoing medical treatment with antipsychotic drugs.
Key exclusion criteria
None reported any neurological disorder, hearing dysfunction, traumatic brain injury, or previous substance abuse or addiction.
Target sample size
20
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Shiga Tetsuya |
Organization
Fukushima Medical University
Division name
Department of Neuropsychiatry
Zip code
Address
1 Hikarigaoka, Fukushima City
TEL
0245471331
tetsuya3@fmu.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Shiga Tetsuya |
Organization
Fukushima Medical University
Division name
Department of Neuropsychiatry
Zip code
Address
1 Hikarigaoka, Fukushima City
TEL
0245471331
Homepage URL
tetsuya3@fmu.ac.jp
Sponsor or person
Institute
Fukushima Medical University
Institute
Department
Personal name
Funding Source
Organization
Fukushima Medical University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 12 | Month | 19 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2013 | Year | 04 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2014 | Year | 04 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Relationships between MMN and plasma monoamine levels
Management information
Registered date
| 2018 | Year | 12 | Month | 18 | Day |
Last modified on
| 2018 | Year | 12 | Month | 18 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000040220
